Wird geladen...
Novel therapeutic approaches for the treatment of castration-resistant prostate cancer()
Prostate cancer is a leading cause of cancer death in men in developed countries. Once the tumor has achieved a castration-refractory metastatic stage, treatment options are limited with the average survival of patients ranging from two to three years only. Recently, new drugs for treatment of castr...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Pergamon
2013
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3834152/ https://ncbi.nlm.nih.gov/pubmed/23792785 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jsbmb.2013.06.002 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|